Healthcare -
Biotechnology - NASDAQ - US
$ 5.48
1.48 %
$ 326 M
Market Cap
-7.31
P/E
Price Target
Average
94.65%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
80.95%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aldeyra Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ALDX of $10.7 , with forecasts ranging from
a
low of
$10 to a high of $12 .
ALDX Lowest Price Target
Wall Street Target
10 USD
82.48%
ALDX Average Price Target
Wall Street Target
10.7 USD
94.65%
ALDX Highest Price Target
Wall Street Target
12 USD
118.98%
REVENUE FORECAST
Revenue Forecast Chart ALDX
EBIT FORECAST
EBIT Forecast Chart ALDX
NET INCOME FORECAST
Net Income Chart ALDX